Book Value per Share: uniQure Corp (QURE)

Graphic logo of uniQure N.V. (QURE)

This chart of the market valuation of uniQure N.V. (QURE) demonstrates the asset's dynamics, where the key indicator is 4.66. uniQure N.V. (QURE) leads in the treatment of hemophilia due to its own manufacturing plants and established gene transport systems. R&D monetization is driven by high-cost single-dose injections and patent protection. Meanwhile, the business strictly adheres to bio-waste disposal regulations and implements energy-efficient technologies.

uniQure Corp (QURE) Equity per Share: for the period 07/04/2022 - 10/28/2026

QURE (uniqure.com): analytical breakdowns and indicator data

- price and consensus price forecast:
Price Chart uniQure Corp|QURE - Fair Value Consensus
- market capitalization data:
Market Capitalization uniQure N.V.|QURE - Total Enterprise Value
- book capitalization data:
Book Value per Share uniQure|QURE - Accounting Capitalization|Market Value to Book Value Ratio uniqure.com|QURE - Total Business Assets
- debt and liquidity data:
Total Debt to Capital uniQure N.V.|QURE - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio uniQure|QURE - Company Aggregate Debts|Debt to Book Capitalization Ratio uniQure N.V.|QURE - Company Long-Term Indebtedness|Company Short-Term Debts uniQure
Fundamental company valuation:uniQure N.V.
Manufactured products of uniQure NV

Book value per share represents the portion of equity attributable to a single security. For uniQure N.V. (QURE), this metric reflects a financial safety buffer given the company's reliance on a single commercial drug. The trend in book value per share demonstrates the company's ability to maintain assets amidst market competition. This metric allows for an assessment of the business's intrinsic value, excluding market speculation. It serves as a critical indicator of solvency and resilience to operational risks.

Competitors of uniQure N.V. (QURE)

Net Assets per Single Share Tempus AI, Inc. (TEM)|QGEN - Accounting Value of a Share|Book Value per Share IONS|repligen.com (RGEN) - Net Asset Value per Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|SRPT - Book Value per Share|Twist Bioscience, Inc. - Accounting Value per Share|TXG: Book Value per Share|Net Assets per Single Share Intellia|Stoke Corp (STOK) - Equity per Share|BLFS: Book Value per Share|Net Assets per Share WVE|MAZE: Net Assets per Single Share|Book Value of One Share Sionna Therapeutics, Inc. SION|Accounting Value per Share PRME (Prime Medicine Corp)|Taysha Corp - Book Value per Share|Net Assets per Single Share MeiraGTx Holdings plc (MGTX)|RGNX - Accounting Value of a Share|Book Value per Share SLDB|Net Asset Value per Share Ocugen Inc|PACB - Accounting Value per Share|Accounting Value of a Share BNTC|Net Assets per Single Share Design Therapeutics DSGN|Equity per Share rocketpharma.com RCKT|Accounting Value per Share FDMT|LXEO - Net Assets per Share|KRRO - Accounting Value per Share|Editas Corp (EDIT) - Net Assets per Single Share|Silence Therapeutics - Accounting Value per Share|PRQR (ProQR Therapeutics) - Net Assets per Share|Codexis Inc - Net Assets per Single Share|Book Value of One Share Sangamo Therapeutics Inc. (SGMO)|Accounting Value per Share NAUT|Book Value per Share MGX (Metagenomi Therapeutics)|Net Assets per Single Share Precision BioSciences, Inc.|Accounting Value of a Share Generation Bio Co GBIO|BOLD (Boundless Bio) - Book Value per Share|XCUR - Net Asset Value per Share|Book Value per Share imunon.com|PHIO (Phio Pharmaceuticals Corp.) - Equity per Share|Net Assets per Single Share Mustang Bio Inc (MBIO)|Equity per Share TransCode|Book Value per Share BNGO|Book Value per Share Applied DNA Sciences Inc APDN|Accounting Value per Share BLUE (Bluebird Bio)|ImmunoPrecise Antibodies Ltd - Book Value per Share|Omega Therapeutics (OMGA) - Net Assets per Single Share|OMIC - Equity per Share|Regulus Therapeutics Inc. - Book Value per Share|SYRS (Syros Pharmaceuticals Inc.) - Net Assets per Share|Codex DNA - Net Assets per Single Share|Book Value of One Share TRACON Pharmaceuticals, Inc (TCON)|Accounting Value per Share UBX